logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Jinxin Fertility (01951.HK) repurchased 2.046 million shares for approximately HK$4.6546 million on November 17.

date
17/11/2026
Zhitong Finance APP News, Jinxin Fertility (01951.HK) announced that on November 17, 2026, the company spent approximately HK$4.6546 million to repurchase 2.046 million shares at a repurchase price of HK$2.245 to HK$2.335 per share.
Latest
11 m ago
Sleek (300382.SZ) Subsidiary Signs Factory-Adjacent Supporting Supply Agreement with CATL
15 m ago
Insilico Medicine (03696.HK) repurchased 369,000 shares for HK$12.608 million on November 17.
16 m ago
On November 16, Novo Nordisk announced the primary results of the STEP Young Phase 3 clinical trial. The trial was designed to evaluate, on the basis of caloric restriction and increased physical activity, the investigational once-weekly semaglutide injection at maximum doses of 1.7 mg or 2.4 mg based on baseline body weight, in patients aged 6 to
17 m ago
Jingwang Electronics (03228) A-share stock trading abnormal fluctuations; no major undisclosed information that should be disclosed
19 m ago
Jinxin Fertility (01951.HK) repurchased 2.046 million shares for approximately HK$4.6546 million on November 17.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.